| The ESSAG-trial protocol: A randomized controlled trial evaluating the efficacy of offering a self-sampling kit by the GP to reach women underscreened in the routine cervical … E Gezels, K Van Roy, M Arbyn, P Coursier, D Devroey, P Martens, ... Contemporary Clinical Trials, 107617, 2024 | | 2024 |
| Evaluation of the Allplex HPV assay’s adherence to international guidelines for cervical cancer screening in clinician-collected samples PYJ Chung, SK Dhillon, S Cortoos, H Hamerlinck, R Pereira, E Padalko, ... Microbiology Spectrum, e00332-24, 2024 | | 2024 |
| Intra‐and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay PYJ Chung, SK Dhillon, A Baraquin, Y Tkachenka, K Jacquot, JL Prétet, ... Journal of Medical Virology 96 (6), e29688, 2024 | | 2024 |
| Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient … C Dun, M Yuan, X Zhao, S Hu, M Arbyn, F Zhao Cancer Medicine 13 (11), e7316, 2024 | | 2024 |
| Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer M Arbyn, P Rousta, L Bruni, L Schollin Ask, P Basu JNCI: Journal of the National Cancer Institute 116 (6), 775-778, 2024 | | 2024 |
| Acceptance of Self-Sampling by Women Not Regularly Participating in Cervical Cancer Screening in Areas with Low Medical Density: A Qualitative Study within the French CapU4 Trial J Le Goff, AS Le Duc-Banaszuk, C Lefeuvre, A Pivert, A Ducancelle, ... Cancers 16 (11), 2066, 2024 | 1 | 2024 |
| Corrigendum: Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening C Lefeuvre, H De Pauw, AS Le Duc Banaszuk, A Pivert, A Ducancelle, ... International Journal of Public Health 69, 1607299, 2024 | | 2024 |
| Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance JL Prétet, LSA Mühr, K Cuschieri, MD Fellner, RM Correa, MA Picconi, ... Journal of Clinical Virology 171, 105657, 2024 | 1 | 2024 |
| Knowledge of cytology results affects the performance of colposcopy: a crossover study E Lalande, H Clarke, M Undurraga, VQH Nguyen, C Jaksic, F Goffin, ... BMC Women's Health 24 (1), 189, 2024 | | 2024 |
| 2023 global inventory of commercial molecular tests for human papillomaviruses (HPV) M Poljak, AO Valenčak, K Cuschieri, KB Bohinc, M Arbyn Journal of Clinical Virology, 105671, 2024 | 1 | 2024 |
| Attitudes of health professionals regarding the use of HPV testing on vaginal self samples or urine in cervical cancer screening, assessed in the French CapU4 study J Le Goff, ASLD Banaszuk, C Lefeuvre, A Pivert, A Ducancelle, ... EUROGIN-INTERNATIONAL MULTIDISCIPLINARY HPV CONGRESS, 2024 | | 2024 |
| Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis L Downham, I Jaafar, ML Rol, V Nyawira Nyaga, J Valls, A Baena, ... British Journal of Cancer 130 (4), 517-525, 2024 | 3 | 2024 |
| Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples M Martinelli, A Latsuzbaia, J Bonde, H Pedersen, AD Iacobone, F Bottari, ... Microbiology spectrum 12 (3), e02872-23, 2024 | 4 | 2024 |
| Assessment of the clinical and analytical performance of three Seegene Allplex SARS-CoV-2 assays within the VALCOR framework PYJ Chung, SK Dhillon, C Simoens, L Cuypers, L Laenen, J Bonde, ... Microbiology Spectrum 12 (2), e02397-23, 2024 | | 2024 |
| Clinical performance of the novel full‐genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework CE Cocuzza, SK Dhillon, M Martinelli, C Giubbi, RC Njoku, R Bhatia, ... International Journal of Cancer 154 (3), 538-547, 2024 | | 2024 |
| Methods for meta-analysis and meta-regression of binomial data: concepts and tutorial with Stata command metapreg VN Nyaga, M Arbyn Archives of Public Health 82 (1), 14, 2024 | 1 | 2024 |
| Baseline assessment of cervical cancer screening and treatment capacity in 25 counties in Kenya, 2022 V Mwenda, D Murage, C Kilonzo, JP Bor, P Njiri, L Osiro, M Nyangasi, ... Frontiers in Oncology 14, 2024 | | 2024 |
| Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women R Rezhake, Y Wang, X Zhao, M Arbyn, G Shen, Q Pan, X Zhang, Y Zhang, ... Vaccines 12 (1), 46, 2023 | | 2023 |
| Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population KT Simms, A Keane, DTN Nguyen, M Caruana, MT Hall, G Lui, ... Nature Medicine 29 (12), 3050-3058, 2023 | 12 | 2023 |
| Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV MT Hall, KT Simms, JM Murray, A Keane, DTN Nguyen, M Caruana, G Lui, ... Nature Medicine 29 (12), 3059-3066, 2023 | 3 | 2023 |
